| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | EXAS Exact Sciences Corp | Herriott James75 | General Counsel | Sell | 1,300 | $100.00 | $130,000.00 | -17.9% | -30.5% | -51.8% | |
| Jul 18, 2023 | VCYT Veracyte, Inc. | Bishop John L | Director | Sell | 20,000 | $30.25 | $605,002.00 | -23.2% | -28.5% | -15.1% | |
| Jul 18, 2023 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 52,809 | $30.09 | $1,588,918.17 | -24.5% | -28.5% | -15.1% | |
| Jul 13, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 5,260 | $10.33 | $54,357.37 | -1.1% | -41.8% | +57.4% | |
| Jul 13, 2023 | CDNA Caredx, Inc. | Maag Peter84 | Director | Sell | 5,000 | $10.34 | $51,680.50 | -1.6% | -41.8% | +57.4% | |
| Jul 7, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 25,116 | $20.04 | $503,425.10 | -6.0% | -26.8% | -14.3% | |
| Jul 7, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 50,000 | $20.39 | $1,019,500.00 | -16.9% | -26.8% | -14.3% | |
| Jul 3, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,818 | $8.48 | $23,900.87 | -0.6% | -19.2% | +75.5% | |
| Jul 3, 2023 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 45 | $5.99 | $269.55 | -1.0% | -36.2% | +369.7% | |
| Jul 3, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 83 | $5.99 | $497.17 | -0.7% | -36.2% | +369.7% | |
| Jun 29, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 4,656 | $51.01 | $237,484.31 | -2.3% | -4.9% | +120.9% | |
| Jun 28, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 14,268 | $8.76 | $125,016.22 | -2.8% | -16.1% | +64.1% | |
| Jun 28, 2023 | CDNA Caredx, Inc. | Maag Peter84 | Director | Sell | 2,432 | $8.72 | $21,215.55 | -0.8% | -16.1% | +64.1% | |
| Jun 28, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 5,447 | $50.83 | $276,868.27 | -0.5% | -12.6% | +113.7% | |
| Jun 28, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,605 | $50.88 | $132,544.74 | -1.2% | -12.6% | +113.7% | |
| Jun 28, 2023 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 728 | $50.88 | $37,041.30 | -0.4% | -12.6% | +113.7% | |
| Jun 26, 2023 | TMO Thermo Fisher Scientific Inc. | Boxer Michael A59 | SVP And General Counsel | Buy | 4 | $526.15 | $2,104.60 | - | -3.1% | +6.6% | |
| Jun 20, 2023 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 1,549 | $6.37 | $9,865.14 | -14.2% | -36.7% | +327.0% | |
| Jun 20, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 2,744 | $6.37 | $17,472.99 | -11.7% | -36.7% | +327.0% | |
| Jun 20, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 1,221 | $6.37 | $7,774.40 | -4.9% | -36.7% | +327.0% | |
| Jun 20, 2023 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 7,965 | $6.37 | $50,726.91 | -11.4% | -36.7% | +327.0% | |
| Jun 16, 2023 | PSNL Personalis, Inc. | Moore Stephen Michael52 | General Counsel | Sell | 1,509 | $2.07 | $3,123.63 | -1.8% | -33.5% | -34.9% | |
| Jun 16, 2023 | VCYT Veracyte, Inc. | Bhanji Muna59 | Director | Sell | 5,893 | $26.44 | $155,785.55 | -9.4% | -3.4% | -19.6% | |
| Jun 16, 2023 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 6,904 | $2.07 | $14,291.28 | -3.4% | -33.5% | -34.9% | |
| Jun 16, 2023 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 4,817 | $2.07 | $9,971.19 | -3.7% | -33.5% | -34.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.